The purpose of this study is to assess the ease of use, preference, and safety after 8 weeks subcutaneous administration of EutropinPen Inj. in patients pretreated with recombinant human growth hormone by reusable device.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
116
Ajou university hospital
Suwon, Gyeonggi-do, South Korea
Ease of use for EutropinPen Inj. against previous reusable device assessed by a questionnaire.
Time frame: Day 57
Preference for EutropinPen Inj. against previous reusable device assessed by a questionnaire.
Time frame: Day 57
Benefits of EutropinPen inj. assessed by a questionnaire
1. Ease of use 2. Unit 3. High dose packing 4. Grip 5. Design 6. Less pain
Time frame: Day 57
Fear assessed by a questionnaire
Ask of fearness how the child feels about the needle
Time frame: Screening, Day 57
Ease of use for EutropinPen Inj. at each injection step assessed by a questionnaire
1. Ask ease of use at each injection step (1\~5 pts) 2. Preparation time for injection
Time frame: Screening, Day 57
Treatment compliance of EutropinPen Inj. (%)
Time frame: Day 57
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.